Immunoglobulins Market Outlook Showing Demand Growth Across 2026–2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Immunoglobulins Market Expected To Change Between 2026 And 2030?

The immunoglobulins market has experienced significant growth in recent years. It is projected to expand from $20.32 billion in 2025 to $22.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. This historical expansion can be attributed to factors such as the rising prevalence of immunodeficiency diseases, an increasing number of autoimmune disorder cases, improvements in hospital infrastructure, technological advancements in plasma fractionation, and broadening awareness about antibody therapies.

The immunoglobulins market is anticipated to experience substantial expansion over the upcoming years. Its valuation is projected to reach $34.52 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. This anticipated expansion throughout the forecast period stems from factors such as progress in personalized medicine, the creation of innovative monoclonal antibodies, a rise in home-based subcutaneous treatments, the broadening of biotechnology and research facilities, and increasing governmental backing for immunotherapy initiatives. Significant developments expected during this forecast span encompass individualized immunoglobulin therapies, a growing preference for subcutaneous delivery techniques, an escalating need for ivig in the treatment of autoimmune conditions, the broadening of available treatments for rare immunodeficiencies, and an increase in research focused on monoclonal antibodies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp

What Drivers Are Expected To Influence The Immunoglobulins Market During The Forecast Period?

The anticipated increase in healthcare spending is expected to propel the growth of the hyperphosphatemia treatment market going forward. Hyperphosphatemia treatment involves therapies and medications aimed at reducing elevated phosphate levels in the blood, which commonly occur in patients with chronic kidney disease and other related conditions. Greater healthcare spending allows for broader access to such treatments, supports research and development of advanced therapies, and improves patient management strategies. For instance, in November 2023, the Canadian Institute for Health Information projected Canada’s total health spending for 2023 to reach $344 billion, equating to $8,740 per person. This represents a 2.8% increase compared to 2022, which had only a 1.5% growth in health spending, indicating a notable rebound in healthcare investment. Therefore, the increasing healthcare expenditure is a key driver for the growth of the hyperphosphatemia treatment market.

How Is The Immunoglobulins Market Structured Across Different Segments?

The immunoglobulins market covered in this report is segmented –

1) By Product: IGG, IGA, IGM, IGE, IGD

2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications

Subsegments:

1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin), SCIG (Subcutaneous Immunoglobulin)

2) By IGA (Immunoglobulin A): Monoclonal IGA, Polyvalent IGA

3) By IGM (Immunoglobulin M): Monoclonal IGM, Polyvalent IGM

4) By IGE (Immunoglobulin E): Allergen-Specific IGE, Monoclonal IGE

5) By IGD (Immunoglobulin D): Research-Use IGD, Monoclonal IGD

Which Trends Are Shaping The Future Of The Immunoglobulins Market?

Leading companies within the immunoglobulins market are focused on developing innovative offerings, such as intravenous immunoglobulins, to expand their customer base, boost sales, and enhance revenue. For instance, in September 2024, GC Biopharma, a biotechnology company based in South Korea, launched ALYGLO (Immune Globulin Intravenous, Human-stwk) 10% Liquid in the U.S. market. This product targets the treatment of primary humoral immunodeficiency (PI) in adults aged 17 years and older and is now accessible to patients through specialty pharmacies. This launch is particularly significant given that the U.S. represents the largest immunoglobulin market globally, with an approximate valuation of $11.6 billion. GC Biopharma aims to generate $50 million in sales for ALYGLO in its inaugural year, with projections to increase this figure to $300 million by 2028. This ambitious growth strategy involves forming partnerships with major U.S. pharmacy benefit managers and specialty pharmacies, which are essential for the effective distribution of immunoglobulin products.

Which Major Players Dominate The Immunoglobulins Market?

Major companies operating in the immunoglobulins market are Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited

Read the full immunoglobulins market report here:

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Which Region Is Forecast To Lead The Immunoglobulins Market In Terms Of Market Size?

North America was the largest region in the immunoglobulins market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Immunoglobulins Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=5284&type=smp

Browse Through More Reports Similar to the Global Immunoglobulins Market 2026, By The Business Research Company

Immunoglobulins Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Hyperimmune Globulins Market Report 2026

https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795